2000
DOI: 10.1073/pnas.110078997
|View full text |Cite
|
Sign up to set email alerts
|

Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease

Abstract: Huntington's disease (HD) is a fatal inherited neurodegenerative disorder characterized by personality changes, motor impairment, and subcortical dementia. HD is one of a number of diseases caused by expression of an expanded polyglutamine repeat. We have developed several lines of mice that are transgenic for exon 1 of the HD gene containing an expanded CAG sequence. These mice exhibit a defined neurological phenotype along with neuronal changes that are pathognomonic for the disease. We have previously obser… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

26
266
3
1

Year Published

2001
2001
2011
2011

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 393 publications
(296 citation statements)
references
References 34 publications
26
266
3
1
Order By: Relevance
“…Several studies suggest that amyloid aggregate toxicity can trigger apoptotic and/or necrotic cell death [2,3,16,44,61]. It is generally believed that cell death associated with protein aggregates begins with stimulation of the apoptotic response, although recent data show necrotic rather than apoptotic death in some cases [33,65,67,72]. The biochemistry of cell death following exposure to the toxic amyloid aggregates is still under investigation, but our results support these suggestions.…”
Section: Discussionsupporting
confidence: 77%
“…Several studies suggest that amyloid aggregate toxicity can trigger apoptotic and/or necrotic cell death [2,3,16,44,61]. It is generally believed that cell death associated with protein aggregates begins with stimulation of the apoptotic response, although recent data show necrotic rather than apoptotic death in some cases [33,65,67,72]. The biochemistry of cell death following exposure to the toxic amyloid aggregates is still under investigation, but our results support these suggestions.…”
Section: Discussionsupporting
confidence: 77%
“…The precise cell death pathway may also vary between disorders. For example, although the animal model of juvenile Huntington disease included in this analysis showed apoptotic neurodegeneration, models containing large numbers of glutamine repeats show evidence of nonapoptotic cell death 28 . Autophagy is a caspase-independent mode of cell death that seems to be involved in some neurodegenerations 15 , but both caspases and autophagy can be simultaneously activated in dying cells, and so different cell types and contexts may trigger the use of caspases, the ubiquitin-proteasome pathway, autophagy or perhaps other mechanisms to destroy the cell 4,15 .…”
Section: Interpreting Allometric Differencesmentioning
confidence: 96%
“…Although pcd has often been equated with apoptosis, it has become increasingly clear that nonapoptotic forms of pcd also exist. [1][2][3][4][5][6][7][8][9][10][11][12][13] For example, certain developmental cell deaths, such as 'autophagic' cell death [1][2][3][4][5] and 'cytoplasmic' cell death, 2,4,6-9 do not resemble apoptosis. Furthermore, neurodegenerative diseases such as Huntington's disease and amyotrophic lateral sclerosis demonstrate neuronal cell death that does not fulfill the criteria for apoptosis.…”
Section: Introductionmentioning
confidence: 99%
“…Furthermore, neurodegenerative diseases such as Huntington's disease and amyotrophic lateral sclerosis demonstrate neuronal cell death that does not fulfill the criteria for apoptosis. 10,11 Ischemiainduced cell deaths may also display a nonapoptotic morphology, referred to as 'oncosis.' 13 The biochemical mechanisms underlying these alternative morphological forms of cell death remain incompletely defined.…”
Section: Introductionmentioning
confidence: 99%